Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AMLODIPINE Cause Nasopharyngitis? 778 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 778 reports of Nasopharyngitis have been filed in association with AMLODIPINE (Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide). This represents 1.2% of all adverse event reports for AMLODIPINE.

778
Reports of Nasopharyngitis with AMLODIPINE
1.2%
of all AMLODIPINE reports
40
Deaths
422
Hospitalizations

How Dangerous Is Nasopharyngitis From AMLODIPINE?

Of the 778 reports, 40 (5.1%) resulted in death, 422 (54.2%) required hospitalization, and 175 (22.5%) were considered life-threatening.

Is Nasopharyngitis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AMLODIPINE. However, 778 reports have been filed with the FAERS database.

What Other Side Effects Does AMLODIPINE Cause?

Hypotension (6,504) Toxicity to various agents (5,554) Completed suicide (5,267) Drug ineffective (4,091) Dyspnoea (3,907) Dizziness (3,536) Intentional overdose (3,427) Fall (3,215) Fatigue (3,141) Headache (2,907)

What Other Drugs Cause Nasopharyngitis?

ADALIMUMAB (13,753) ETANERCEPT (12,421) METHOTREXATE (8,046) TOFACITINIB (7,781) SECUKINUMAB (7,022) TOCILIZUMAB (6,664) RITUXIMAB (6,321) ABATACEPT (6,143) INFLIXIMAB (5,353) CERTOLIZUMAB PEGOL (5,295)

Which AMLODIPINE Alternatives Have Lower Nasopharyngitis Risk?

AMLODIPINE vs AMLODIPINE BESILATE AMLODIPINE vs AMLODIPINE\ATORVASTATIN AMLODIPINE vs AMLODIPINE\BENAZEPRIL AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL

Related Pages

AMLODIPINE Full Profile All Nasopharyngitis Reports All Drugs Causing Nasopharyngitis AMLODIPINE Demographics